Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD

NCT03059849 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT03059849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03059849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD
Lead sponsor
McMaster University
Phase
Phase 4
Overall status
Withdrawn
Start date
February 1, 2018
Completion date
September 1, 2019
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, ulcerative colitis